Our results demonstrated that when CRC cells were exposed to the combination of BEZ235 and BMS-1166, the wound size in the wound-healing assays was significantly more than with BMS-1166 or BEZ235 monotherapy, and the expression levels of MMP-2 and MMP-9 were reduced. Here, MMP9 is linked to colorectal carcinoma.